Search

Displaying results 8391 - 8400 of 10000 in total
  1. Drug

    Aneratrigine

    go.drugbank.com/drugs/DB21639
    Experimental

    Aneratrigine has a monoisotopic molecular weight of 487.07 Da. … Aneratrigine is a small molecule drug. The usage of the INN stem '-trigine' in the name indicates that Aneratrigine is a sodium channel blocker, signal transduction modulator.

  2. Drug

    Resigratinib

    go.drugbank.com/drugs/DB21664
    Experimental

    Resigratinib has a monoisotopic molecular weight of 523.21 Da. … Resigratinib is a small molecule drug. The usage of the INN stem '-gratinib' in the name indicates that Resigratinib is a fibroblast growth factor receptor (FGFR) inhibitor.

  3. Drug

    Lirodegimod

    go.drugbank.com/drugs/DB21675
    Experimental

    Lirodegimod has a monoisotopic molecular weight of 1256.45 Da. … Lirodegimod is a small molecule drug. The usage of the INN stem '-imod' in the name indicates that Lirodegimod is a immunomodulator, both stimulant/suppressive and stimulant.

  4. Drug

    Fanregratinib

    go.drugbank.com/drugs/DB21688
    Experimental

    Fanregratinib has a monoisotopic molecular weight of 508.24 Da. … Fanregratinib is a small molecule drug. The usage of the INN stem '-gratinib' in the name indicates that Fanregratinib is a fibroblast growth factor receptor (FGFR) inhibitor.

  5. Drug

    Ilantimod

    go.drugbank.com/drugs/DB21742
    Experimental

    Ilantimod has a monoisotopic molecular weight of 387.11 Da. … Ilantimod is a small molecule drug. The usage of the INN stem '-imod' in the name indicates that Ilantimod is a immunomodulator, both stimulant/suppressive and stimulant.

  6. Drug

    Tenecteplase

    go.drugbank.com/drugs/DB00031
    ApprovedInvestigational

    It is a 527 amino acid with a substitution of threonine 103 with asparagine and substitution of asparagine 117 with glutamine within the kringle 1 domain, and a tetra-alanine substitution at amino acids … Tenecteplase is a tissue plasminogen activator (tPA) developed from modifications of natural human tPA complementary DNA (cDNA).

    Products: METALYSE FOR INJECTION 10,000 u/vial
  7. Drug

    Etoperidone

    go.drugbank.com/drugs/DB09194
    ApprovedWithdrawn

    It is a phenylpiperazine-substituted triazole derivative with a composition that classifies it as an analog of tradozone and presents a similar pharmacological profile.

  8. Drug

    MCC

    go.drugbank.com/drugs/DB05282
    Investigational

    The product is a sterile biological composition in a sub-micron suspension. It is produced at the Bioniche manufacturing facility in Pointe-Claire, Quebec. … Mycobacterial Cell Wall-DNA Complex (MCC) is formulated from Mycobacterium phlei, a non-pathogenic strain of mycobacteria.

  9. Drug

    G305

    go.drugbank.com/drugs/DB17292
    Investigational

    G305 is a [recombinant NY-ESO-1 protein] plus glucopyranosyl lipid A (GLA) in a stable emulsion (SE). G305 is an active component of CMB305 along with [LV305].[L47346]

  10. Drug

    LB-001

    go.drugbank.com/drugs/DB17685
    Experimental

    LB-001 is a gene editing therapy designed to incorporate a functioning version of the faulty methylmalonyl-COA mutase (MUT) gene into the genome of patients with methylmalonic acidemia.